Weekly Pharma Notes: Bristol-Myers Squibb, Pfizer, Merck And Roche

It was another eventful week for pharmaceutical companies studded with acquisition announcements, investors expecting potential bids, alliances and new therapeutic agents getting regulatory approval. There wasn't a lot of movement in share prices, though, as the events were not too significant.